CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 4/A Grant or award President & CEO acquired 26,467 shares (grant or award)
- 4/A Grant or award President & CEO acquired 0 shares (grant or award)
- 8-K Event Other events
- 4 Open-market buy Chief Financial Officer bought 2,246 shares at $4.30 ($9,658)
- 8-K Event Executive or director change
- 4 Grant or award President and CEO acquired 26,367 shares (grant or award)
- 8-K/A Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 13,252 shares (grant or award)
- 4 Open-market buy Director bought 754 shares at $3.98 ($3,001)
- 4 Grant or award President and CEO acquired 26,467 shares (grant or award)
- 4 Grant or award Director acquired 7,045 shares (grant or award)
- 4 Grant or award General Counsel & Secretary acquired 13,000 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 3,769 shares at $3.98 ($15,001)
- SC 13D/A Stake Beneficial Ownership Report
- 4 Open-market buy 10% owner bought 181,800 shares at $2.75 ($499,950)
- 4 Open-market buy Director bought 6,281 shares at $3.98 ($24,998)
Page 14 of 78 · 1,549 filings